Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-970
Closed -$204K 398
2026
Q1
$204K Hold
970
0.03% 368
2025
Q4
$276K Hold
970
0.04% 332
2025
Q3
$299K Sell
970
-155
-14% -$48.6K 0.04% 340
2025
Q2
$353K Hold
1,125
0.05% 297
2025
Q1
$295K Hold
1,125
0.05% 281
2024
Q4
$294K Buy
+1,125
New +$283K 0.05% 272
2024
Q3
Sell
-1,365
Closed -$275K 386
2024
Q2
$275K Buy
+1,365
New +$246K 0.06% 258
2024
Q1
Sell
-1,010
Closed -$219K 298
2023
Q4
$219K Buy
+1,010
New +$173K 0.05% 262
2023
Q3
Sell
-850
Closed -$245K 301
2023
Q2
$245K Hold
850
0.06% 261
2023
Q1
$271K Hold
850
0.07% 241
2022
Q4
$250K Buy
+850
New +$234K 0.06% 257
2022
Q2
Sell
-1,400
Closed -$373K 323
2022
Q1
$373K Hold
1,400
0.08% 224
2021
Q4
$372K Buy
1,400
+650
+87% +$189K 0.07% 242
2021
Q3
$213K Buy
+750
New +$214K 0.05% 311

Other funds holding PODD

Chicago Trust's PODD Position: Q2 2026 in Review

Chicago Trust sold out of Insulet (PODD) in Q2 2026, closing a stake of 970 shares — an estimated $204K sold.

Chicago Trust first reported a position in PODD in Q3 2021 and held it in 14 quarters. The position peaked at $373K in Q1 2022. 100 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Chicago Trust reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Chicago Trust sold 970 Insulet shares in Q2 2026, an estimated $204K.
  • Chicago Trust first reported a position in Insulet in Q3 2021 and held it in 14 quarters.
  • Chicago Trust's Insulet position peaked at $373K in Q1 2022.
  • 100 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.